Jeff Porter Sharman
Impact in
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 146
- Chronic Lymphocytic Leukemia Research 146
-
- Lymphoma Diagnosis and Treatment 112
- Co-authors
- Richard R. Furman (28 shared papers)Ranjana H. Advani (11 shared papers)Kathryn S. Kolibaba (25 shared papers)Raquel Izumi (4 shared papers)Thomas E. Boyd (16 shared papers)Steven E. Coutre (24 shared papers)Nathan Hale Fowler (13 shared papers)Ahmed Hamdy (2 shared papers)
- Journals
- Blood (79 papers)Blood Advances (11 papers)Hematological Oncology (11 papers)Haematologica (7 papers)HemaSphere (7 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Jeff Porter Sharman
188 papers receiving 12.4k citations
Jeff Porter Sharman's Hit Papers
Peers
Comparison fields: 5 of 118
- Genetics 8.8k
- Pathology and Forensic Medicine 7.1k
- Hematology 2.3k
- Immunology 3.3k
- Oncology 2.8k
Countries citing papers authored by Jeff Porter Sharman
This map shows the geographic impact of Jeff Porter Sharman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Porter Sharman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Porter Sharman more than expected).
Fields of papers citing papers by Jeff Porter Sharman
This network shows the impact of papers produced by Jeff Porter Sharman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Porter Sharman. The network helps show where Jeff Porter Sharman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Porter Sharman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia Hit paper breakdown → | 2013 | 1942 |
| 2 | Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia Hit paper breakdown → | 2014 | 1431 |
| 3 | Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies Hit paper breakdown → | 2012 | 957 |
| 4 | Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes Hit paper breakdown → | 2013 | 699 |
| 5 | Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia Hit paper breakdown → | 2009 | 637 |
| 6 | Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial Hit paper breakdown → | 2020 | 493 |
| 7 | 2013 | 404 | |
| 8 | 2018 | 332 | |
| 9 | 2020 | 295 | |
| 10 | 2014 | 284 | |
| 11 | 2015 | 270 | |
| 12 | 2015 | 243 | |
| 13 | 2014 | 242 | |
| 14 | 2017 | 226 | |
| 15 | 2019 | 212 | |
| 16 | 2019 | 199 | |
| 17 | 2015 | 164 | |
| 18 | 2022 | 153 | |
| 19 | 2020 | 149 | |
| 20 | 2010 | 147 |
About Jeff Porter Sharman
Jeff Porter Sharman is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Immunology and Oncology, having authored 192 papers that have together received 12.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (146 papers), Lymphoma Diagnosis and Treatment (112 papers), Chronic Myeloid Leukemia Treatments (28 papers), Immunodeficiency and Autoimmune Disorders (26 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), CAR-T cell therapy research (16 papers), Viral-associated cancers and disorders (12 papers) and Acute Lymphoblastic Leukemia research (11 papers). The work is most often cited by research in Genetics (8.8k citations), Pathology and Forensic Medicine (7.1k citations), Hematology (2.3k citations), Immunology (3.3k citations) and Oncology (2.8k citations). Jeff Porter Sharman has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Richard R. Furman, Ranjana H. Advani, Kathryn S. Kolibaba, Raquel Izumi, Thomas E. Boyd, Steven E. Coutre, Nathan Hale Fowler, Ahmed Hamdy, Betty Y Chang and Sven de Vos. Their work appears in journals such as Blood, Blood Advances, Hematological Oncology, Haematologica and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.